Intellia Therapeutics, Inc.
NasdaqGM:NTLA
$ 25.42
+ $0.96 (3.92%)
$ 25.42
+ $0.96 (3.92%)
End-of-day quote: 05/13/2024

NTLA: Global investment alternatives & competitors

Competitors

Ticker Price Forecast 1Y Forecast 2Y Market Cap Div Yld Growth Rate
ASX:CSL
CSL
279.92 22.63% 43.58% 135,272.1 1.28% 7.18%
TSE:4502
Takeda Pharmaceutical Company
4102.00 0% 0% 6,435,766.66 4.75% 0%
NasdaqGS:BMRN
BioMarin Pharmaceutical
80.50 142.2% 221.62% 15,385.96 0% 32.46%
NasdaqGS:IONS
Ionis Pharmaceuticals
38.80 -,156.68% -,149.23% 5,756.54 0% 0%
NasdaqGS:BCRX
BioCryst Pharmaceuticals
5.63 0% 0% 1,087.36 0% 0%
ENXTAM:PHARM
Pharming Group N.V.
0.88 -,641.75% 1,467.17% 591.95 0% 0%
NasdaqGM:KALV
KalVista Pharmaceuticals
12.00 0% 0% 478.84 0% 0%